Steven Cohen’s Gilead Sciences GILD Stock Holding History

Steven Cohen’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.05M	Sell	8,300 -4,100	-33%	-$540K	﹤0.01%	2807
2026 Q1	$1.73M	Sell	12,400 -4,400	-26%	-$616K	﹤0.01%	2413
2025 Q4	$2.06M	Buy	+16,800	New	+$2.04M	﹤0.01%	2452
2025 Q2	–	Sell	-75,000	Closed	-$8.4M	–	2353
2025 Q1	$8.4M	Buy	+75,000	New	+$7.74M	0.02%	745
2022 Q1	–	Sell	-500,000	Closed	-$36.3M	–	1245
2021 Q4	$36.3M	Buy	+500,000	New	+$34.4M	0.15%	192
2017 Q3	–	Sell	-500,000	Closed	-$35.4M	–	937
2017 Q2	$35.4M	Buy	+500,000	New	+$33.3M	0.2%	140

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Steven Cohen's GILD Position: Q2 2026 in Review

Steven Cohen increased its Gilead Sciences (GILD) stake by 16,222% in Q2 2026, buying an estimated $188M and bringing the position to 1,437,685 shares worth $182M. The position accounts for 0.2% of the portfolio, ranked #84.

Steven Cohen first reported a position in GILD in Q4 2014 and has held it in 28 quarters since. The position peaked at $232M in Q1 2018. 2,265 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Steven Cohen held 1,437,685 shares of Gilead Sciences worth $182M as of Q2 2026.
Steven Cohen bought 1,428,877 Gilead Sciences shares in Q2 2026, an estimated $188M.
Gilead Sciences made up 0.2% of Steven Cohen's portfolio in Q2 2026, its #84 holding.
Steven Cohen first reported a position in Gilead Sciences in Q4 2014 and has held it in 28 quarters since.
Steven Cohen's Gilead Sciences position peaked at $232M in Q1 2018.
2,265 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.